Filing Details
- Accession Number:
- 0001144204-15-014248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-05 16:30:20
- Reporting Period:
- 2015-03-03
- Filing Date:
- 2015-03-05
- Accepted Time:
- 2015-03-05 16:30:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1523662 | Binh Nguyen | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vp Of Medical Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-03 | 40,000 | $3.55 | 58,242 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-03 | 29,883 | $5.79 | 28,359 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-03-03 | 40,000 | $0.00 | 40,000 | $3.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- Shares sold to cover option exercise cost, taxes and fees.
- Represents the sale of 29,883 shares in multiple transactions, ranging in price from $5.72 to $5.91 per share, resulting in a weighted average sale price of $5.7888. The reporting person will provide, upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.